T790M mutation positive 2nd line STandard of cAre Registry

Trial Identifier: D5160R00001
Sponsor: AstraZeneca
Collaborator:
Parexel
Start Date: June 2015
Primary Completion Date: June 2018
Study Completion Date: June 2018
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations